Patents by Inventor Georg Hoffmann

Georg Hoffmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970037
    Abstract: A method for controlling a vertical vibration damping of a wheel of a vehicle, in which the wheel has a suspension including a vibration damper with a control element including an actuating element for adapting a damping characteristic of the vibration damper includes a series of steps. The vehicle includes a first sensor for detecting roadway anomalies, a second sensor for detecting a vertical displacement of the wheel, and a control unit connected to the first and second sensors and the control element. The method steps include detecting roadway anomalies with the first sensor, detecting the vertical displacement with the second sensor and switching the vibration damper with the control element at a first point in time from a first state with a first damping characteristic into a second state with a second damping characteristic when a first sensor signal generated by the first sensor indicates a roadway anomaly with a minimum height.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: April 30, 2024
    Assignee: Ford Global Technologies, LLC
    Inventors: Cyril Coerman, Uwe Hoffmann, Georg Johann Maurer
  • Patent number: 11958810
    Abstract: Preparation of optionally substituted dihydroisoquinolines. The present invention relates to a process for the preparation of optionally substituted dihydroi-soquinolines of the formula I.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 16, 2024
    Assignee: BASF SE
    Inventors: Bernd Mueller, Michael Rack, Michael Seet, Ana Escribano Cuesta, Jan Klaas Lohmann, Georg Christoph Rudolf, Markus Nett, Rainer Hoffmann
  • Publication number: 20120028939
    Abstract: The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 is selected from among —O—R3 or —NR3R4, R3 is C1-6-alkyl which is substituted by R5 and R6, R5 is selected from hydrogen, branched or linear C1-6-alkyl, C2-6-alkenyl, —C1-6-alkylen-O—C1-3-alkyl, C1-3-haloalkyl, R6 is ring X wherein n is either 0 or 1, and is a either a single or a double bond and wherein A, B, D and E are each independently from one another selected from CH2, CH, C, N, NH, O or S and wherein ring X is attached to the molecule either via position A, B, D or E, wherein said ring X may optionally be further substituted by one, two or three residues each selected individually from the group consisting of -oxo, hydroxy, —C1-3-alkyl, —C1-3-haloalkyl, —O—C1-3-alkyl, —C1-3-alkanol and halogen, and wherein R4, R2, R7, R8, R9, R10, R11 and Q may have the meanings as given in claim 1, as wel
    Type: Application
    Filed: January 26, 2011
    Publication date: February 2, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Matthias Hoffmann, Georg Hoffmann, Dennis Fiegen, Sandra Handschuh, Jasna Klicic, Guenter Linz, Gerhard Schaenzle, Andreas Schnapp, Stephen Peter East, Michael Philip Mazanetz, Robert John Scott, Edward Walker